Influenza & COVID-19 Obstetric and Perinatal Epidemiology Study in India
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Boston University
- Study ID
- NCT06168019
- Status
- Recruiting
Conditions
- COVID-19
- Infant Morbidity
- Influenza
- Other Respiratory Viruses
- Perinatal Morbidity
- SARS-COV-2 Infection
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 50 Years
- Healthy Volunteers
- Not accepted
Interventions
- Exposures — OTHERCOVID-19, Influenza and ORV impact on the pregnant woman, her fetus and newborn
Study Details
This study will be conducted as a prospective cohort study, enrolling all eligible women in their first trimester of pregnancy during a baseline visit during week 6-13 of pregnancy at Government Medical College Hospital, Nagpur. The Hospital provides primary, secondary, and tertiary care and the obstetric department delivers about 10,000 babies a year. The hypothesis is that co-infection of other respiratory viruses (ORV), particularly COVID-19 and Influenza increases the risk of adverse pregnancy outcomes in mothers and babies and could address the current standard of care in India to not vaccinate pregnant women during pregnancy, by either encouraging vaccination against both viruses before planning a pregnancy or during pregnancy based on global data supporting the safety of this strategy.
Key Dates
- Start date
- Dec 26, 2023
- Status verified
- Nov 2025
- Primary completion
- Jun 30, 2028
- Completion
- Jun 30, 2028
Study Design
- Enrollment
- 10,000 participants (estimated)
Arms
- Arm: Influenza & COVID-19 Obstetric and Perinatal Epidemiology (ICOPE)Pregnant women in their first trimester of pregnancy who present to the outpatient antenatal care clinic at Government Medical College Hospital in Nagpur, India.
Primary Outcome Measure
Maternal composite adverse outcome variable [ Time Frame: 1 year ]
Central Contacts
- Patricia Hibberd, MD PhD617-358-2046
- Aboli Goghari, MPH617-358-2310
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Boston University School of Public Health, Global Health | Boston | Massachusetts | 02118 | Patricia Hibberd, MD PhD Aboli Goghari, MPH |
Find similar trials in Boston, MA
Related Studies
- Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT StudyPHASE3 · Recruiting · Ansun Biopharma, Inc. · Duarte, California
- Positron Emission Tomography (PET) Imaging of ThrombosisPHASE1 · Recruiting · Massachusetts General Hospital · Boston, Massachusetts
- EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe DiseasePHASE3 · Recruiting · Pfizer · Phoenix, Arizona
- Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVIDPHASE3 · Recruiting · Wes Ely · Tucson, Arizona